Prothya Biosolutions supplies customers worldwide with plasma-derived medicines and processes blood plasma on behalf of biopharmaceutical companies.
Plasma-drived medicines Cofact, Albuman and Nanogam
Prothya Biosolutions is an independent marketing authorization holder in Europe for the products Cofact, Albuman and Nanogam. Outside of Europe, our partners are the marketing authorization holders.
These plasma-derived medicines are supplied directly by us, or by our trusted partners, through a global network to healthcare organizations.
In Europe, our products are available in a growing number of countries. Outside of Europe, we collaborate with parties such as Centurion Pharma (Turkey) and Blau Pharma (Brazil) to supply our products in the Middle East and Latin America.
Several brand names are used in this process:
- Cofact, FourFact, Hyfact
- Albuman, Crealb, Blaubimax
- Nanogam, Optiglobin, Blauimuno
Contract manufacturing for the biopharmaceutical industry
In addition to supplying plasma-derived medicines, Prothya Biosolutions acts as a contract manufacturer for various companies in the biopharmaceutical industry. In doing so, we supply intermediate products as well as finished products. Among our customers are the French company LFB, Germany’s Biotest and Japan’s Takeda.